Citation Impact
Citing Papers
Escherichia coli induces DNA damage in vivo and triggers genomic instability in mammalian cells
2010
In Vivo Activation of the p53 Pathway by Small-Molecule Antagonists of MDM2
2004 StandoutScience
Intestinal Inflammation Targets Cancer-Inducing Activity of the Microbiota
2012 StandoutScience
Similar Nucleotide Excision Repair Capacity in Melanocytes and Melanoma Cells
2010 StandoutNobel
The AKT-mTOR pathway plays a critical role in the development of leiomyosarcomas
2007 Standout
DNA adduct burden and tobacco carcinogenesis
2002
p53 mediated death of cells overexpressing MDM2 by an inhibitor of MDM2 interaction with p53
1999
Sperm DNA integrity in relation to exposure to environmental perfluoroalkyl substances – A study of spouses of pregnant women in three geographical regions
2012
mTOR Signaling in Growth Control and Disease
2012 Standout
The RB and p53 pathways in cancer
2002 Standout
Integrated analysis of somatic mutations and focal copy-number changes identifies key genes and pathways in hepatocellular carcinoma
2012 Standout
TIGAR, a p53-Inducible Regulator of Glycolysis and Apoptosis
2006 Standout
Intrinsically unstructured proteins and their functions
2005 Standout
Cisplatin: mode of cytotoxic action and molecular basis of resistance
2003 Standout
p53-Mdm2--the affair that never ends
2002
HIF-Dependent Antitumorigenic Effect of Antioxidants In Vivo
2007 StandoutNobel
The gut microbiota, bacterial metabolites and colorectal cancer
2014 Standout
Role of the SCFSkp2 Ubiquitin Ligase in the Degradation of p21Cip1 in S Phase
2003 StandoutNobel
Cisplatin Resistance: A Cellular Self-Defense Mechanism Resulting from Multiple Epigenetic and Genetic Changes
2012
Ki-67 detected by MIB-1 predicts distant metastasis and tumor mortality in primary, high grade extremity soft tissue sarcoma
1998
Head and neck cancer
2008 Standout
Cellular Senescence in Cancer and Aging
2007 Standout
Neuroblastoma: biological insights into a clinical enigma
2003 Standout
Soft-Tissue Sarcomas in Adults
2005 Standout
A Genome-wide RNAi Screen for Modifiers of the Circadian Clock in Human Cells
2009
Expression of p21WAF1/CIP1 in Soft Tissue Sarcomas: A Comparative Immunohistochemical Study with p53 and Ki-67
1998
ROS Function in Redox Signaling and Oxidative Stress
2014 Standout
Intestinal‐specific PPARγ deficiency enhances tumorigenesis in ApcMin/+ mice
2006
High resolution analysis of DNA copy number variation using comparative genomic hybridization to microarrays
1998 Standout
Identification of two distinct chromosome 12-derived amplification units in neuroblastoma cell line NGP
1995
Blinded by the Light: The Growing Complexity of p53
2009 Standout
The antioxidant function of the p53 tumor suppressor
2005
p21 in cancer: intricate networks and multiple activities
2009 Standout
ROS as signalling molecules: mechanisms that generate specificity in ROS homeostasis
2007 Standout
Circadian clock control of the cellular response to DNA damage
2010 StandoutNobel
DNA amplifications at 20q13 and MDM2 define distinct subsets of evolved breast and ovarian tumours
1996
mTOR: from growth signal integration to cancer, diabetes and ageing
2010 Standout
Self-consumption: the interplay of autophagy and apoptosis
2014 Standout
The MDM2 gene amplification database
1998
p53 in health and disease
2007 Standout
A small synthetic peptide, which inhibits the p53-hdm2 interaction, stimulates the p53 pathway in tumour cell lines 1 1Edited by A. R. Fersht
2000
Free radicals and antioxidants in normal physiological functions and human disease
2006 Standout
The roles of PTEN in development, physiology and tumorigenesis in mouse models: a tissue-by-tissue survey
2008 StandoutNobel
Molecular and biological roles of Ape1 protein in mammalian base excision repair
2005
Reflecting on 25 years with MYC
2008 Standout
Tobacco Smoke Carcinogens and Lung Cancer
1999 Standout
SWELL1, a Plasma Membrane Protein, Is an Essential Component of Volume-Regulated Anion Channel
2014 StandoutNobel
The Ki-67 protein: From the known and the unknown
2000 Standout
Cisplatin in cancer therapy: Molecular mechanisms of action
2014 Standout
TP53 allele loss, mutations and expression in malignant melanoma
1994
p53 Target Genes Sestrin1 and Sestrin2 Connect Genotoxic Stress and mTOR Signaling
2008
Polycyclic aromatic hydrocarbon-DNA adducts in humans: relevance as biomarkers for exposure and cancer risk
1998
Design of a synthetic Mdm2-binding mini protein that activates the p53 response in vivo
1997
The fundamental role of epigenetic events in cancer
2002 Standout
Targeting cancer cells by ROS-mediated mechanisms: a radical therapeutic approach?
2009 Standout
The molecular basis of ATM-dependent dimerization of the Mdc1 DNA damage checkpoint mediator
2012 StandoutNobel
The first 30 years of p53: growing ever more complex
2009 Standout
Patterns of p53 G->T transversions in lung cancers reflect the primary mutagenic signature of DNA-damage by tobacco smoke
2001
Transfection-Mediated Cell-Cycle Signaling: Considerations for Transient Transfection-Based Cell-Cycle Studies
1999
Complete switch from Mdm2 to human papillomavirus E6-mediated degradation of p53 in cervical cancer cells
2001 StandoutNobel
Ubiquitination of p53 and p21 Is Differentially Affected by Ionizing and UV Radiation
1997
EDC-2: The Endocrine Society's Second Scientific Statement on Endocrine-Disrupting Chemicals
2015 Standout
NAT1/DAP5/p97 and Atypical Translational Control in the Drosophila Circadian Oscillator
2012 StandoutNobel
Cytochrome P450 1A1 MspI polymorphism and urinary 1-hydroxypyrene concentrations in coke-oven workers.
1998
Methylated CpG dinucleotides are the preferential targets for G-to-T transversion mutations induced by benzo[a]pyrene diol epoxide in mammalian cells: similarities with the p53 mutation spectrum in smoking-associated lung cancers.
2001
Fat and Beyond: The Diverse Biology of PPARγ
2008 Standout
Signals for Sorting of Transmembrane Proteins to Endosomes and Lysosomes
2003 Standout
Molecular Genetics and Cytogenetics of Sarcomas
1995
MDM2 Suppresses p73 Function without Promoting p73 Degradation
1999 StandoutNobel
Mdm-2: “big brother” of p53
1997
Mnt Takes Control as Key Regulator of the Myc/Max/Mxd Network
2007
Tumor suppressor genes and related molecules in leiomyosarcoma.
1996
Oxidative Stress: An Essential Factor in the Pathogenesis of Gastrointestinal Mucosal Diseases
2014 Standout
HdmX stimulates Hdm2-mediated ubiquitination and degradation of p53
2003 StandoutNobel
5-Hydroxymethylfurfural and 5-sulfooxymethylfurfural increase adenoma and flat ACF number in the intestine of Min/+ mice.
2009
c-Abl Regulates p53 Levels under Normal and Stress Conditions by Preventing Its Nuclear Export and Ubiquitination
2001 StandoutNobel
THE UBIQUITIN SYSTEM
1998 StandoutNobel
Regulation of Mammalian Autophagy in Physiology and Pathophysiology
2010 Standout
Hydroxymethylfurfural, A Versatile Platform Chemical Made from Renewable Resources
2013 Standout
Works of Åshild Andreassen being referenced
Urinary excretion of 1-hydroxypyrene as a marker for exposure to urban air levels of polycyclic aromatic hydrocarbons.
1998
Molecular portrait of cisplatin induced response in human testis cancer cell lines based on gene expression profiles
2007
2-Amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) induces genetic changes in murine intestinal tumours and cells with ApcMin mutation
2006
Comparative synchronous fluorescence spectrophotometry and 32P-postlabelling analysis of PAH-DNA adducts in human lung and the relationship to TP53 mutations
1996
Effects of per- and polyfluorinated compounds on adult rat testicular cells following in vitro exposure
2011
Adenomatous polyposis coli truncation mutations in 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP)-induced intestinal tumours of multiple intestinal neoplasia mice
2003
MDM2 Gene Amplification and Transcript Levels in Human Sarcomas: Relationship to TP53 Gene Status
1994
p53 abnormalities in different subtypes of human sarcomas.
1993
Intestinal tumours induced by the food carcinogen 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine in multiple intestinal neoplasia mice have truncation mutations as well as loss of the wild-type Apc+ allele
2001
Intestinal tumorigenesis in multiple intestinal neoplasia mice induced by the food mutagen 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine: perinatal susceptibility, regional variation, and correlation with DNA adducts.
2001